Posts by: Joana Fernandes, PhD

Joana Fernandes, PhD

Joana brings more than 8 years of academic research and experience as well as Scientific writing and editing to her role as a Science and Research writer. She also served as a Postdoctoral Researcher at the Center for Neuroscience and Cell Biology in Coimbra, Portugal, where she also received her PhD in Health Science and Technologies, with a specialty in Molecular and Cellular Biology.

May 15, 2017May 15, 2017

Biosimilar CT-P13 Can Safely Replace Much More Expensive Remicade as RA Treatment, Study Finds

News

Rheumatoid arthritis (RA) patients taking Remicade (infliximab) can safely switch to CT-P13 (developed by Celltrion) — a much cheaper biosimilar of Remicade — according to a Norwegian study published in The Lancet. ... Read more

April 12, 2017April 12, 2017

Obesity May Alter Diagnosis, Management of RA When Blood Tests Are Used

News, rheumatoid arthritis

Obesity in women may interfere with the diagnosis and monitoring of rheumatoid arthritis (RA) through blood tests, according to a new study. Researchers call for more attention to the ... Read more

March 27, 2017March 27, 2017

Antibodies Against Collagen II Protein May Predict Good Prognosis in RA Patients

News, rheumatoid arthritis

Antibodies against a protein called collagen II may be associated with a good prognosis in patients with rheumatoid arthritis (RA), according to the results of a recent study. The ... Read more

March 17, 2017March 17, 2017

EULAR Recommends Use of JAK Inhibitors, Including Xeljanz, for RA Management

News, rheumatoid arthritis

The European League Against Rheumatism (EULAR) has recommended the use of janus kinase (JAK) protein inhibitors, such as Pfizer’s Xeljanz (tofacitinib citrate), for the management of rheumatoid arthritis (RA). EULAR’s ... Read more

March 6, 2017March 6, 2017

Transcript of Interview with Rheumatologist, Dr. Ara Dikranian

News, rheumatoid arthritis

Rheumatoid Arthritis News interviewed Dr. Ara Dikranian, a rheumatologist at the Cabrillo Center for Rheumatic Disease in El Cajon, California, about his experience in talking with rheumatoid arthritis (RA) ... Read more

March 6, 2017March 6, 2017

In Interview, Rheumatologist Talks of Intimacy and Relationship Concerns of RA Patients

News

People with chronic diseases — of which rheumatoid arthritis (RA) is one — need to talk openly with their doctors about topics that might be uncomfortable, such as their ... Read more

February 20, 2017February 20, 2017

Vaccine Against Pneumococcal Pneumonia May Not Prevent Infection in RA Patients

News, rheumatoid arthritis

Vaccination against pneumococcal pneumonia may not protect patients with rheumatoid arthritis (RA) at risk of infection from pneumonia, according to the results of a clinical trial in Japan. The ... Read more

February 8, 2017February 8, 2017

Sanofi’s Kevzara Approved in Canada as Treatment for Moderate to Severe RA

News

Kevzara (sarilumab) has been approved in Canada as a treatment for adult patients with moderate to severe rheumatoid arthritis (RA) who are either intolerant or considered inappropriate candidates to be ... Read more

January 16, 2017January 16, 2017

RA Treatment with TNF Inhibitors Greatly Decreases Heart Attack Risk, UK Study Finds

News

The risk of heart attack associated with rheumatoid arthritis (RA) may decrease by nearly half when TNF inhibitors (TNFi) are part of the treatment, according to new research conducted ... Read more

December 19, 2016December 19, 2016

Specific Bacterium May Be Link Between RA and Gum Disease, Study Finds

News

A bacterium that causes gum infections may also contribute to inflammation leading to chronic joint-destroying rheumatoid arthritis (RA), according to new research. This could provide useful information on how ... Read more